All Journal Guides

Journal Guide

PLOS Medicine Impact Factor 12.4: Publishing Guide

PLOS Medicine isn't just another open access journal. It's where clinical research meets global health policy, and where editors actively seek work that'll change how medicine gets practiced in both Boston and Bamako.

12.4

Impact Factor (2024)

~15%

Acceptance Rate

6-8 weeks to first decision

Time to First Decision

What PLOS Medicine Publishes

PLOS Medicine wants clinical and health research that matters beyond your specialty. The editors aren't looking for incremental advances in treatment protocols or yet another observational study confirming what we already suspected. They're hunting for work that changes clinical practice, reshapes public health policy, or reveals something genuinely new about how diseases affect populations. There's a strong preference for studies with immediate real-world applications, particularly those relevant to low and middle-income countries. If your findings only matter to subspecialists at a handful of academic medical centers, you'll want to look elsewhere.

  • Large-scale clinical trials with practice-changing implications, especially those testing interventions accessible to resource-limited settings rather than expensive biologics available only in wealthy countries.
  • Epidemiological studies that reveal new patterns in disease burden, risk factors, or health disparities, particularly when the findings suggest actionable interventions.
  • Health policy research that evaluates real-world implementation of medical interventions, healthcare delivery models, or public health programs across diverse settings.
  • Systematic reviews and meta-analyses that settle clinical debates or synthesize evidence in ways that directly inform treatment guidelines and policy decisions.
  • Global health research addressing infectious diseases, maternal and child health, non-communicable disease epidemics, and health systems strengthening in underserved populations.

Editor Insight

“I see hundreds of submissions where authors clearly haven't read our journal. They send us single-center studies with narrow specialist appeal, then seem surprised when we return them without review. What we're really looking for is work that a health minister could use, that a clinician in a district hospital in Tanzania could apply, that changes how we think about a disease burden affecting millions. I desk-reject papers that might be technically fine but have no obvious path to impact. Your cover letter needs to tell me who'll change their behavior because of your findings. If it's just other researchers in your subfield, that's not enough for us. We also value methodological transparency intensely - if reviewers find gaps between your reported methods and your data, that's usually fatal. Be honest about limitations rather than hiding them. The papers that succeed here are ones where authors understood our mission before they started writing.”

What PLOS Medicine Editors Look For

Global relevance over local significance

PLOS Medicine editors consistently favor studies that speak to populations beyond North America and Western Europe. A well-conducted trial from Kenya or Bangladesh often gets more attention than another study from Massachusetts General. This doesn't mean your US-based research won't succeed, but you'll need to frame it in terms of what it means for global health broadly. The editors are explicitly trying to platform research from and about underrepresented regions.

Policy-ready conclusions

Your discussion section shouldn't end with 'more research is needed.' PLOS Medicine wants papers that tell policymakers and clinicians what to do differently starting tomorrow. If your findings don't translate into actionable recommendations, the editors will question whether the journal is the right fit. Think about who needs to read your paper and what specific decision it helps them make. Abstract implications won't cut it here.

Methodological rigor that withstands scrutiny

The journal has built its reputation partly on publishing high-quality trials and observational studies with bulletproof methods. Reviewers will examine your statistical approach, your handling of confounders, and your sensitivity analyses with unusual care. Pre-registration is essentially mandatory for trials. If you've deviated from your original protocol, you'd better have documented exactly why and how. The journal also requires data sharing, so don't submit if you can't comply.

Clear public health impact

PLOS Medicine papers routinely get picked up by mainstream media and shape policy discussions. Editors select work partly based on whether it'll generate that kind of attention for the right reasons. They're not looking for clickbait, but they do want research that matters to people outside academia. Your cover letter should articulate why a journalist or health minister would care about your findings. If you can't explain that clearly, reconsider your submission.

Equity and access considerations

Research that only benefits wealthy populations in high-income countries faces a steeper climb here than at most journals. PLOS Medicine has made health equity a core editorial priority. If you're studying an intervention, can it actually be implemented where disease burden is highest? If you're examining risk factors, have you considered how they operate differently across socioeconomic contexts? Papers that ignore these questions often get desk-rejected, regardless of methodological quality.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past PLOS Medicine's editorial review:

Framing findings in purely biomedical terms without public health context

Authors often write their PLOS Medicine submissions the same way they'd write for a specialty clinical journal, focusing on mechanisms and clinical details while ignoring broader implications. This misses what makes the journal distinctive. Editors want to know how your findings affect population health, healthcare systems, and policy decisions. A paper about diabetes treatment that only discusses HbA1c without addressing cost, accessibility, or implementation in different healthcare settings will likely face rejection before peer review.

Submitting single-center studies without exceptional justification

PLOS Medicine strongly prefers multi-site studies, large cohorts, and research with external validity. Single-center studies face immediate skepticism unless they involve a unique population, a natural experiment, or circumstances that couldn't be replicated elsewhere. If you're sending a single-center study, your cover letter needs to make an extremely compelling case for why the findings generalize. Most authors don't make this argument convincingly, and their papers get returned without review.

Inadequate attention to reporting guidelines

The journal enforces CONSORT, STROBE, PRISMA, and other reporting checklists rigorously. Authors who treat these as bureaucratic box-checking rather than genuine quality standards run into problems. Reviewers will check whether you've actually addressed each item substantively, not just claimed compliance. Incomplete reporting checklists or mismatches between your stated methodology and the checklist responses trigger immediate requests for major revision. Don't submit until every item is honestly and thoroughly addressed.

Overlooking the open access data sharing requirement

PLOS Medicine requires underlying data to be publicly available or available upon request with a clear explanation of any restrictions. Authors from clinical settings often underestimate how difficult this can be with patient data, especially internationally. If you haven't figured out your data sharing plan before submission, you'll face delays and possibly rejection at the acceptance stage. Sort out your ethics approvals, anonymization approach, and repository selection before you submit, not after.

Writing for specialists rather than a broad medical audience

PLOS Medicine readers include clinicians, epidemiologists, health economists, and policymakers across many fields. Dense jargon from your subspecialty alienates most of this audience. Authors frequently submit manuscripts written for their narrow field, forcing editors to request extensive rewriting. Your abstract and introduction especially need to be accessible to any physician or public health professional, not just experts in your specific area. Test this by having colleagues from different specialties read your draft.

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against PLOS Medicine's criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from PLOS Medicine Authors

The cover letter matters more here than at most journals

PLOS Medicine editors use cover letters to assess fit before anything else. They're explicitly looking for authors who understand the journal's mission and can articulate why their work belongs there. A generic cover letter recycled from another submission signals you haven't done your homework. Take time to explain the global health implications, the policy relevance, and why this work fits PLOS Medicine specifically rather than a specialty journal.

Consider the magazine section for policy-relevant commentary

Beyond research articles, PLOS Medicine publishes Essays, Perspectives, and Policy Forum pieces that can reach wider audiences than original research. If you have strong opinions backed by evidence on a health policy issue, this might be an easier entry point. These pieces also help you build a relationship with editors before submitting your next research paper.

Preprint posting is encouraged and won't hurt your submission

Unlike some journals that still frown on preprints, PLOS actively encourages them. Posting to medRxiv or a similar server before submission demonstrates confidence in your work and can help you gather feedback. Some authors have found that preprint attention actually helps their PLOS Medicine submission by demonstrating public interest in the findings.

Don't ignore the Author Summary requirement

PLOS Medicine requires a plain-language Author Summary alongside the abstract. This isn't optional filler - it's what journalists and policymakers will read first. Write it for an educated non-specialist, avoid jargon completely, and focus on the 'so what' question. Poor Author Summaries can sink otherwise strong papers because editors worry about how the work will be communicated publicly.

International author teams have an advantage

Submissions from diverse international collaborations, particularly those including researchers from low and middle-income countries, align with the journal's mission. If your study involves populations in these regions, having local co-authors isn't just ethical - it strengthens your submission. Parachute research where Western academics study other populations without local collaboration is increasingly unwelcome.

The PLOS Medicine Submission Process

1

Presubmission inquiry (optional but recommended)

1-2 weeks for response

For papers you're uncertain about, PLOS Medicine offers presubmission inquiries. Send a structured abstract and brief cover letter explaining the work's significance. Editors typically respond within two weeks with guidance on whether to submit. This saves everyone time if the paper doesn't fit.

2

Full manuscript preparation

2-4 weeks depending on complexity

Prepare your manuscript according to PLOS formatting guidelines. Complete all required reporting checklists thoroughly. Write your Author Summary in plain language. Arrange your data sharing plan and verify compliance with ethics requirements. Don't underestimate the time needed for these components.

3

Online submission through Editorial Manager

1-2 hours for complete submission

Submit through the PLOS Medicine portal. Upload your manuscript, figures, supplementary materials, and completed checklists. Your cover letter should explicitly address global health relevance and policy implications. Suggest reviewers who understand both the methods and the public health context.

4

Editorial assessment and triage

2-4 weeks

Senior editors evaluate scope, significance, and initial quality. About half of submissions are returned at this stage without external review. If editors are interested but uncertain, they may send your paper to an Academic Editor with relevant expertise for input before deciding on peer review.

5

Peer review

4-6 weeks typically

Papers that pass triage go to 2-3 external reviewers. PLOS Medicine uses single-blind review by default but offers double-blind on request. Reviewers are asked to assess methodology, significance, and presentation. Statistical review is common for quantitative studies.

6

Decision and revision

Variable; revision windows typically 2-3 months

You'll receive a decision letter with detailed reviewer comments. Major revision is common for papers that will ultimately be accepted. Respond thoroughly to every point, making changes clear in tracked versions. If invited to revise, your chances of eventual acceptance are reasonably good if you address concerns fully.

PLOS Medicine by the Numbers

2024 Impact Factor(Consistent top-tier performance among medical journals)12.4
Acceptance Rate(Highly selective, particularly for research articles)~15%
Time to First Decision(Faster than many comparable journals)6-8 weeks
Article Processing Charge(Fee waivers available for researchers from eligible countries)$5,900 USD
Altmetric Performance(Papers regularly achieve high media and policy attention)Top 5%
Open Access Downloads(Barrier-free access maximizes research impact globally)Millions annually

Before you submit

PLOS Medicine accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to PLOS Medicine. ~30 minutes.

Run Free Readiness ScanSee a sample report

Article Types

Research Article

No strict limit; typically 3,500-5,000 words

Original research including clinical trials, observational studies, and systematic reviews. Must have clear public health or clinical practice implications.

Meta-Research Article

Typically 3,000-4,500 words

Studies examining research practices, publication bias, reproducibility, and the conduct of medical science itself.

Policy Forum

2,500-3,000 words

Analysis of health policy issues with evidence-based recommendations. Often commissioned but unsolicited submissions considered.

Essay

2,000-2,500 words

Evidence-based opinion pieces on topics of broad interest to medicine and public health. Should provoke discussion and offer fresh perspectives.

Perspective

1,500-2,000 words

Shorter commentary pieces responding to recent research or emerging health issues. Timely topics preferred.

Collection Review

Variable by collection

Review articles synthesizing research for themed collections, typically by invitation following successful research article publication.

Landmark PLOS Medicine Papers

Papers that defined fields and changed science:

  • Bhutta et al., 2008 - Demonstrated that proven maternal and child health interventions could prevent millions of deaths in developing countries
  • Murray et al., 2012 - Published the Global Burden of Disease study updating disability-adjusted life year calculations worldwide
  • Dye et al., 2013 - Showed that tuberculosis mortality had fallen 45% since 1990, validating global TB control efforts
  • Horton et al., 2017 - Analyzed the economic case for investing in adolescent health across low and middle-income countries
  • Patel et al., 2010 - Demonstrated effectiveness of lay health worker interventions for depression in primary care settings in India

Preparing a PLOS Medicine Submission?

Get pre-submission feedback from reviewers who've published in PLOS Medicine and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected
Confidential

Primary Fields

Clinical trials and intervention researchGlobal health and health equityInfectious disease epidemiologyNon-communicable disease preventionHealth policy and systems researchMaternal and child healthMental health across populationsEnvironmental and occupational healthImplementation scienceHealth economics and outcomes research

Related Journal Guides

All journal guides

Related Articles

All articles

Ready to submit to PLOS Medicine?

A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what PLOS Medicine editors look for.

Avoid Desk Rejection

Get expert pre-submission review before you submit to PLOS Medicine. 3-7 day turnaround.

Manuscript Rejected?

Expert revision help to strengthen your manuscript and resubmit with confidence.

Reviewer Response Help

Get expert guidance crafting your response to PLOS Medicine reviewers.

Run Free Readiness Scan

Need field-expert depth? Human review from $1,000